These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26952042)

  • 1. Possible Rivaroxaban Failure during the Postpartum Period: An Alternative Viewpoint.
    Bond AM; Bartle B; Rudd KM; McFee Winans AR
    Pharmacotherapy; 2016 Apr; 36(4):e26-7. PubMed ID: 26952042
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of factor Xa inhibitors in venous thromboembolism treatment.
    Cabral KP; Ansell JE
    Vasc Health Risk Manag; 2015; 11():117-23. PubMed ID: 25673997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability.
    Dupree LH; Reddy P
    Ann Pharmacother; 2014 Dec; 48(12):1655-8. PubMed ID: 25169250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.
    Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
    Thromb Res; 2015 Feb; 135(2):388-93. PubMed ID: 25555316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
    Beer JH
    Praxis (Bern 1994); 2011 Aug; 100(16):947. PubMed ID: 21910293
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapy with oral Xa inhibitors for venous thromboembolism.
    Vanassche T; Vandenbriele C; Peerlinck K; Verhamme P
    Expert Opin Pharmacother; 2015 Apr; 16(5):645-58. PubMed ID: 25554350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban for treatment of venous thromboembolism in older adults.
    Mitchell AP; Conway SE
    Consult Pharm; 2014 Sep; 29(9):627-30. PubMed ID: 25203412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Vink R; Sohne M
    N Engl J Med; 2013 May; 368(20):1945. PubMed ID: 23675668
    [No Abstract]   [Full Text] [Related]  

  • 9. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Cohen AT; Spiro TE; Spyropoulos AC;
    N Engl J Med; 2013 May; 368(20):1945-6. PubMed ID: 23675665
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Alameddine R; Husari A
    N Engl J Med; 2013 May; 368(20):1944-5. PubMed ID: 23675666
    [No Abstract]   [Full Text] [Related]  

  • 11. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Derksen RJ; Mulder WM; Mulder JW
    N Engl J Med; 2013 May; 368(20):1945. PubMed ID: 23675667
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rivaroxaban for thromboprophylaxis inpatients with acute medical illness].
    Ruiz Muñoz M
    Rev Clin Esp (Barc); 2013; 213(5):257. PubMed ID: 23940851
    [No Abstract]   [Full Text] [Related]  

  • 13. [New oral anticoagulants in the treatment of venous thromboembolic disease].
    Calvo Romero JM; Lima Rodríguez EM
    Semergen; 2013 Apr; 39(3):146-9. PubMed ID: 23540987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New oral anticoagulants for acute venous thromboembolism.
    Med Lett Drugs Ther; 2014 Jan; 56(1433):3-4. PubMed ID: 24419296
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivaroxaban, the first oral, direct factor Xa inhibitor.
    Fassiadis N
    Expert Opin Pharmacother; 2009 Dec; 10(18):2945-6. PubMed ID: 19925048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Questions--answers on the use of rivaroxaban for the treatment of venous thromboembolic disease].
    Pernod G; Elias A; Gouin I; Gaillard C; Nguyen P; Ouvry P; Sié P
    J Mal Vasc; 2012 Dec; 37(6):300-10. PubMed ID: 23122646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New oral anticoagulants in the management of venous thromboembolism: a major advance?
    Sciascia S; Hunt BJ
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):487-8. PubMed ID: 25150440
    [No Abstract]   [Full Text] [Related]  

  • 18. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G; Becattini C; Franco L
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study).
    Romualdi E; Donadini MP; Ageno W
    Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):841-4. PubMed ID: 21809964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience with rivaroxaban in mechanical valve prosthesis in an animal model.
    Aramendi JI; Mestres CA
    Eur J Cardiothorac Surg; 2014 May; 45(5):920-1. PubMed ID: 24186922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.